Introduction

This page provides a comprehensive analysis of the known insider trading history of Philip Ashman. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Philip Ashman has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ALIM / Alimera Sciences, Inc. President of Int'l Operations 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Philip Ashman. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Philip Ashman as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-09-18 2024-09-16 4 ALIM ALIMERA SCIENCES INC
Common Stock
D - Sale to Issuer -118,274 0 -100.00
2024-04-02 2024-03-26 4 ALIM ALIMERA SCIENCES INC
Common Stock
F - Taxes X -12,103 118,274 -9.28 3.83 -46,354 452,989
2024-01-11 2024-01-10 4 ALIM ALIMERA SCIENCES INC
Common Stock
F - Taxes X -2,938 130,377 -2.20 3.86 -11,344 503,386
2023-03-28 2023-03-26 4 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 103,000 133,315 339.77
2023-02-06 2023-02-03 4 ALIM ALIMERA SCIENCES INC
Common Stock
F - Taxes X -2,889 30,315 -8.70 2.81 -8,119 85,197
2022-01-12 2022-01-10 4 ALIM ALIMERA SCIENCES INC
Common Stock
F - Taxes X -1,175 33,204 -3.42 4.65 -5,464 154,399
2022-01-06 2022-01-04 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 45,000 45,000
2022-01-06 2022-01-04 4 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 15,000 34,379 77.40
2021-04-12 2021-04-08 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale -45 19,379 -0.23 9.62 -433 186,426
2021-03-08 2021-03-04 4 ALIM ALIMERA SCIENCES INC
Common Stock
F - Taxes X -2,533 19,424 -11.54 7.77 -19,681 150,924
2021-01-11 2021-01-07 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 30,000 30,000
2021-01-11 2021-01-07 4 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 10,000 21,957 83.63
2020-11-05 2020-11-04 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 1,316 11,957 12.37 4.50 5,922 53,805
2020-03-19 2020-03-18 4 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 5,389 10,641 102.61
2020-03-03 2020-03-02 4 ALIM ALIMERA SCIENCES INC
Common Stock
F - Taxes X -1,447 5,252 -21.60 6.15 -8,899 32,300
2020-03-03 2020-02-28 4 ALIM ALIMERA SCIENCES INC
Common Stock
F - Taxes X -1,447 6,699 -17.76 7.05 -10,201 47,228
2020-01-14 2020-01-10 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 20,000 20,000
2019-01-31 2019-01-30 4 ALIM ALIMERA SCIENCES INC
Common Stock
F - Taxes X -13,254 29,892 -30.72 0.84 -11,137 25,118
2019-01-31 2019-01-29 4 ALIM ALIMERA SCIENCES INC
Common Stock
F - Taxes X -13,254 43,146 -23.50 0.82 -10,913 35,526
2019-01-25 2019-01-23 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 200,000 200,000
2019-01-25 2019-01-23 4 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 92,300 148,700 163.65
2018-01-25 2018-01-22 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 150,000 150,000
2018-01-25 2018-01-22 4 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 56,400 56,400
2018-01-19 2018-01-19 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -12,750 0 -100.00 1.18 -15,048
2018-01-19 2018-01-18 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -12,750 12,750 -50.00 1.22 -15,504 15,504
2018-01-18 2018-01-17 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -12,750 25,500 -33.33 1.23 -15,695 31,390
2018-01-18 2018-01-16 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -12,750 38,250 -25.00 1.24 -15,779 47,338
2017-01-23 2017-01-20 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 150,000 150,000
2017-01-23 2017-01-20 4 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 51,000 51,000
2016-01-06 2016-01-04 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 125,000 125,000
2015-02-02 2015-01-29 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 125,000 125,000
2013-12-18 2013-12-16 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 65,000 65,000
2013-12-18 2013-12-16 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 135,000 135,000
2013-01-04 2013-01-02 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 200,000 200,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)